Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group

1991 ◽  
Vol 151 (10) ◽  
pp. 2043-2048 ◽  
Author(s):  
M. T. Sullivan
Author(s):  
David M. Rosenberg ◽  
Steve E. Braunstein ◽  
Emma C. Fields ◽  
Erin F. Gillespie ◽  
Jillian R. Gunther ◽  
...  

2021 ◽  
Author(s):  
Pugazhendhi Vijayaraman ◽  
Óscar Cano ◽  
Shunmuga Sundaram ◽  
Manuel Molina-Lerma ◽  
Joseph Y.S. Chan ◽  
...  

2002 ◽  
Vol 81 (3) ◽  
pp. 169-171 ◽  
Author(s):  
Michael McGee ◽  
J.V.D. Hough ◽  
Mark W. Wood

The use of homografts in ossiculoplasty has been well documented in the literature. In the early 1980s, nonossicular homograft otic capsule bone was used as a prosthetic material in stapedectomy. We began using homograft femur as a prosthetic material in the early 1990s. In this article, we report the results of a retrospective study of the use of homograft femur prostheses. A series of 300 stapedectomies was performed between Aug. 24, 1992, and Jan. 20, 2000. Total footplate removal with preservation of the posterior crus was our procedure of choice. However, in 116 of these cases, the posterior crus could not be used, and a homograft femur prosthesis was substituted. For these prostheses, all homograft femurs were obtained from the American Red Cross. All prostheses were prepared in the bone laboratory and stored in the bone bank until needed. After an adequate period of follow-up, we tabulated our results. We found that in 89 of 113 cases (78.8%) available for follow-up, the air-bone gap was completely closed. In addition, the air-bone gap was closed to within 5 dB in 11 patients (9.7%) and closed to within 10 dB in five patients (4.4%). In all, 105 of the 113 homograft femur prosthetic procedures (92.9%) resulted in a successful outcome.


Sign in / Sign up

Export Citation Format

Share Document